Credit Suisse’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$7.81M Sell
415,300
-78,458
-16% -$1.35M 0.01% 1047
2023
Q4
$7.12M Sell
493,758
-4,981
-1% -$67.8K 0.01% 1123
2023
Q3
$8.66M Sell
498,739
-45,891
-8% -$957K 0.01% 964
2023
Q2
$11.3M Buy
544,630
+71,098
+15% +$1.55M 0.01% 868
2023
Q1
$11.1M Buy
473,532
+232,530
+96% +$6.24M 0.01% 883
2022
Q4
$6.73M Buy
241,002
+5,533
+2% +$141K 0.01% 1125
2022
Q3
$5.51M Sell
235,469
-4,803
-2% -$145K 0.01% 1202
2022
Q2
$8.11M Sell
240,272
-7,156
-3% -$251K 0.01% 1022
2022
Q1
$8.64M Buy
247,428
+14,526
+6% +$497K 0.01% 1112
2021
Q4
$7.09M Sell
232,902
-40,987
-15% -$1.33M ﹤0.01% 1747
2021
Q3
$8.98M Sell
273,889
-9,681
-3% -$310K ﹤0.01% 1600
2021
Q2
$8.66M Buy
+283,570
New +$9.33M ﹤0.01% 1659

Other funds holding OGN

Credit Suisse's OGN Position: Q1 2024 in Review

Credit Suisse reduced its Organon & Co (OGN) stake by 16% in Q1 2024, selling an estimated $1.35M and leaving 415,300 shares worth $7.81M. The position accounts for 0.01% of the portfolio, ranked #1047.

Credit Suisse first reported a position in OGN in Q2 2021 and has held it in 12 quarters since. The position peaked at $11.3M in Q2 2023. 720 funds tracked by Wall St. Rank hold OGN as of Q1 2024.

  • Credit Suisse held 415,300 shares of Organon & Co worth $7.81M as of Q1 2024.
  • Credit Suisse sold 78,458 Organon & Co shares in Q1 2024, an estimated $1.35M.
  • Organon & Co made up 0.01% of Credit Suisse's portfolio in Q1 2024, its #1047 holding.
  • Credit Suisse first reported a position in Organon & Co in Q2 2021 and has held it in 12 quarters since.
  • Credit Suisse's Organon & Co position peaked at $11.3M in Q2 2023.
  • 720 funds tracked by Wall St. Rank held Organon & Co as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.